| 6.55 0.32 (5.14%) | 06-12 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 8.3 | 1-year : | 9.97 |
| Resists | First : | 7.11 | Second : | 8.53 |
| Pivot price | 7  |
|||
| Supports | First : | 4.8 | Second : | 3.99 |
| MAs | MA(5) : | 6.37  |
MA(20) : | 6.57 |
| MA(100) : | 5.69 |
MA(250) : | 7.3 |
|
| MACD | MACD : | 0.2 |
Signal : | 0.3 |
| %K %D | K(14,3) : | 34.2 |
D(3) : | 36.9 |
| RSI | RSI(14): 51.2 |
|||
| 52-week | High : | 14.48 | Low : | 3.92 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ ASPI ] has closed above bottom band by 36.0%. Bollinger Bands are 56% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 11 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 6.85 - 6.87 | 6.87 - 6.9 |
| Low: | 6.18 - 6.21 | 6.21 - 6.24 |
| Close: | 6.5 - 6.54 | 6.54 - 6.59 |
ASP Isotopes Inc. is an emerging advanced materials company, currently in its pre-commercial stage. This firm is dedicated to the comprehensive management of isotopes, encompassing their creation, dissemination, promotion, and eventual sale. The company's developmental portfolio includes Molybdenum-100, a non-radioactive isotope designed for medical applications, alongside Carbon-14 and Silicon-28. Furthermore, ASP Isotopes is involved with Uranium-235, a specific uranium isotope considered crucial for the carbon-free energy sector. Established in 2021, the company maintains its headquarters in Boca Raton, Florida.
Wed, 10 Jun 2026
ASP Isotopes (ASPI) COO sells shares under 10b5-1 plan for tax withholding - Stock Titan
Wed, 03 Jun 2026
ASP Isotopes (ASPI) EVP and general counsel granted 400,000-share stock award - Stock Titan
Wed, 03 Jun 2026
ASP Isotopes (ASPI) CEO reports tax-cover share sales and 2.23M-share grant - Stock Titan
Mon, 13 Apr 2026
$333M cash backs ASP Isotopes' 2026 push for first sales - Stock Titan
Mon, 12 Jan 2026
ASP Isotopes Inc. Common Stock (ASPI) Stock Price Today & Analysis - Gotrade
Tue, 21 Oct 2025
Will ASP Isotopes’ (ASPI) Expansion Into Radiopharmacy Redefine Its Advanced Materials Strategy? - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Basic Materials
|
|
|
Industry:
Chemicals
|
|
| Shares Out | 126 (M) |
| Shares Float | 100 (M) |
| Held by Insiders | 13 (%) |
| Held by Institutions | 56.6 (%) |
| Shares Short | 23,080 (K) |
| Shares Short P.Month | 25,330 (K) |
| EPS | -2.22 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 2.29 |
| Profit Margin | 0 % |
| Operating Margin | -595.5 % |
| Return on Assets (ttm) | -13.7 % |
| Return on Equity (ttm) | -103.4 % |
| Qtrly Rev. Growth | 279.2 % |
| Gross Profit (p.s.) | 0.03 |
| Sales Per Share | 0.21 |
| EBITDA (p.s.) | -0.56 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -52 (M) |
| Levered Free Cash Flow | -40 (M) |
| PE Ratio | -2.97 |
| PEG Ratio | 0 |
| Price to Book value | 2.84 |
| Price to Sales | 30.62 |
| Price to Cash Flow | -15.75 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|